Your browser doesn't support javascript.
loading
Research progress on naltrexone in the treatment of children with inflammatory bowel disease / 中国小儿急救医学
Chinese Pediatric Emergency Medicine ; (12): 71-74, 2022.
Article in Chinese | WPRIM | ID: wpr-930808
ABSTRACT
Inflammatory bowel disease refers to a group of non-specific chronic gastrointestinal inflammatory diseases of unknown causes, including ulcerative colitis, Crohn′s disease and indeterminate colitis.Recently, the incidence of inflammatory bowel disease in children has increased, which seriously affects the growth and development of children and the quality of life.Studies have shown that the opioid receptor antagonist naltrexone can reverse the inflammatory activity in inflammatory bowel disease and promote cell repair.This review summarized the research of application of naltrexone in the treatment of inflammatory bowel disease, aiming to further explore the effectiveness and safety of naltrexone in the treatment of inflammatory bowel disease in children.

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Chinese Pediatric Emergency Medicine Year: 2022 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Chinese Pediatric Emergency Medicine Year: 2022 Type: Article